Doern, G V <br/><br/>
In vitro activity of BAY v 3522, a new oral cephalosporin tested against Haemophilus influenzae and Branhamella catarrhalis.  [electronic resource] 

 -  Diagnostic microbiology and infectious disease   
 - 349-52 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0732-8893 
<br/><br/><label>Standard No.: </label>10.1016/0732-8893(90)90030-y  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Amoxicillin--pharmacology<br/>Amoxicillin-Potassium Clavulanate Combination<br/>Ampicillin--pharmacology<br/>Anti-Bacterial Agents--administration & dosage<br/>Benzothiazoles<br/>Cephalosporins--administration & dosage<br/>Clavulanic Acids--pharmacology<br/>Drug Therapy, Combination--pharmacology<br/>Haemophilus influenzae--drug effects<br/>Humans<br/>Microbial Sensitivity Tests<br/>Moraxella catarrhalis--drug effects<br/>Penicillins--pharmacology<br/>beta-Lactamases--biosynthesis